Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Agouron continues to discover MMP inhibitors

April 19, 1996

PD-154309 revealed at 211th ACS

April 19, 1996

AntiCancer, Celltech present gelatinase A inhibitor at NCI-EORTC

April 19, 1996

Estrasine presented at NCI-EORTC

April 19, 1996

CB-30865 selected for further study

April 19, 1996

Onconase development update

April 19, 1996

Immune Response in-licenses gene therapy for brain tumors

April 12, 1996

NT-3 lessens cisplatin toxicity in rats

April 12, 1996

Thalidomide in phase II at NCI for cancer indications

April 12, 1996

Banyu reports synthesis and activity of BE-39907A2

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...